TNBC cohort and AR-negative TNBC patients were more likely to express PD-L1 (p=0.05), CTLA-4 (p=0.001), and IDO1 (p=2.8e-05). Spearman correlation test showed a positive ... PIK3CA (0.39), and PTEN (0.11). Differential…
CD45+ cells from the combination treatment group also demonstrated a significant upregulation of PD-L1 expression on the cell surface. Specifically, this upregulation in the PD-L1 expression was observed
Uveal melanoma (UM) is characterized by low PD-L1 expression, low mutational burden and limited efficacy with checkpoint inhibition. IMCgp100 is a bispecific T cell redirector with an affinity-enhanced ... influx of…
biomarkers are vital for immune checkpoint blockade in solid tumors. Established markers include PD-L1 expression, \textit{Tumor Mutational Burden} (TMB), and Microsatellite Instability (MSI), guiding personalized…
prognosis of various malignancies has been widely observed, recently. However, the association between PD-L1 expression and breast cancer patients’ survival remains controversial. Thus, we performed this study to assess…
Selection of patients who are likely to respond to immunotherapy is based on PD-L1 expression, a specific biomarker. Clinic-pathological correlation of PD-L1 status and NSCLC has been ... looked at a series of lung…
novel class of tumor suppressor in HCC—‘immune’ tumor suppressor, effectively downregulating neoplastic PD-L1 expression in abnormal hepatocytes or HCC cells to boost immune surveillance as shown in NRAS ... WSX1…
blood lymphocytes (PBLs) with IL-10 pretreated PTC cells. Programmed death-ligand 1 (PD-L1) expression was measured in PTC tissues and IL-10 pretreated cells ... production along with decreased IFN-γ secretion and PD-1…
prognosis. Recent Publications: 1. Wang X, Teng F, Kong L, Yu J. PD-L1 expression in human cancers and its association with clinical outcomes. Onco Targets Ther ... Cancer. Front Oncol.2020;10:1644…
from anti-PD-1/anti-PD-L1. Patients with tumours that do not express PD-L1 can still benefit from treatment, nevertheless. To increase the response rates to PD ... causes immunogenic alterations in cancer cells, has the…
constructed using two cores from each tumor block. The expression of CD4, CD8, FOXP3, CD20, CD68, CD163, PD-1, PD-L1, PTEN and phosphoSTAT1 was determined by immunohistochemistry. Results ... lymphocytes (CD4+ , CD8+…
found to be related with histological grading of tumor. Meanwhile, the high expression of PD-L1 in CTC surface has also been reported. Since PDL1 can mediate Treg to play ... cancer patients. We have also analyzed the…
investigated the effect of these boron derivatives on the PD1/PD-L1 expression and we found that these molecules increased the PD1/PD-L1 expression leading to suppression ... effect on the breast cancer cells but on the…
pair binds, cytotoxic T cell function is inhibited. Many types of tumors can express PD-L1 as a mechanism to evade the antitumor response of the immune system ... PD-L1 clone. The use of these antibodies and the…
Furthermore, one of the leading causes for immune suppression is elevated expression of PD-L1 either by the tumor cells or the surrounding regulatory cells, resulting in dysfunction of TILs ... microenvironment, leading…
which have been associated with better outcomes. The prognostic values of TILs and PD-L1 expression on tumor cells have been an area of interest and remain uncertain to date ... discuss the immunogenic nature of TNBC…
immune inhibitory receptor, expressed in many cells, including T cells. Its ligand, PD-L1, is expressed on surface of several cell types, especially tumor cells. When PD-L1 binds ... mutational load. High mutational…
described about thyroid hormone-tetrac receptor on integrin α vβ3. NDAT inhibits PD-L1 inducible expression and protein accumulation by inhibition of activated ERK1/2 and PI3K. Knockdown PD-L1 ... oral cancer cells…
treatment of several malignant tumors, including IUC. Our work identified the expression of PD-L1 in Muscle-Invasive Bladder Carcinoma (MIBC), a field little explored at present, using a validated ... specimens) of MIBC…
ARSI have revealed the outlines of an innate immunity integration response that includes PD-L1 expression and alterations in cGAS-pSTING and pSTAT1/3, which drive the immunoevasion ... 10XG) of PEFF prostate sections…
increase in Tregs. TNBC patient samples harbored CD38 tumoral expression that correlated with PD-L1 expression. Consequently, cotargeting CD38 and PD-L1 in hybrid EM murine models delayed tumor growth
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.